Nanoliposomes, Liposomes and Solid Lipid Nanoparticles: Novel Drug Delivery Strategies
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (23 October 2023) | Viewed by 3731
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue emphasizes new research avenues and recent developments in the application of nanoliposomes, liposomes, and solid lipid nanoparticles, including diagnostics, targeted therapy, and gene and peptide delivery. Surface modifications of these systems may further provide unique features such as enhanced targeting capability. Pharmaceuticals, cosmetics, and nutraceuticals can all be delivered using this class of delivery systems to treat many genetic, communicable, and non-communicable diseases. The aforementioned nanosystems can be used to modify drug absorption, reduce metabolism, prolong half-life, and reduce drug toxicity. Other advantages include being simple to scale up, biocompatible, biodegradable, and nontoxic, as they are formulated from acceptable biocompatible excipients. Hence, you are invited to participate by submitting original research or review articles to this Special Issue, helping to advance this groundbreaking topic.
Dr. Amal El-Kamel
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene therapy
- protein delivery
- nutraceuticals
- theragnostic
- bioavailability
- cancer
- infections
- Alzheimer’s disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.